// App-Quantinova.ai

526 : Effectiveness of opicapone in Parkinson’s disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study

Researchers

Presenter

  • N. Pavese

Principal Investigators

  • A. Lees

  • H. Reichmann

  • D. Martins

  • D. Magalhaes

  • J. Rocha

  • P. Soares-da-Silva

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • Safinamide

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved